Dr. Nicholas Leeper, MD

NPI: 1407044639
Total Payments
$87,022
2023 Payments
$1,074
Companies
9
Transactions
61
Medicare Patients
4,097
Medicare Billing
$140,778

Payment Breakdown by Category

Consulting$67,850 (78.0%)
Travel$13,586 (15.6%)
Other$4,450 (5.1%)
Food & Beverage$1,136 (1.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $67,850 26 78.0%
Travel and Lodging $13,586 9 15.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,450 1 5.1%
Food and Beverage $1,136 25 1.3%

Top Paying Companies

Company Total Records Latest Year
Janssen Scientific Affairs, LLC $25,143 20 $0 (2020)
SANOFI US SERVICES INC. $22,046 4 $0 (2020)
Janssen Pharmaceuticals, Inc $15,587 19 $0 (2020)
Astellas Pharma Inc $13,282 7 $0 (2017)
Janssen Research & Development, LLC $6,045 4 $0 (2017)
E.R. Squibb & Sons, L.L.C. $3,686 1 $0 (2018)
Regeneron Pharmaceuticals, Inc. $1,074 2 $0 (2023)
Gilead Sciences, Inc. $87.55 3 $0 (2018)
PFIZER INC. $72.18 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $1,074 2 Regeneron Pharmaceuticals, Inc. ($1,074)
2020 $15,065 13 Janssen Pharmaceuticals, Inc ($5,611)
2019 $18,542 5 SANOFI US SERVICES INC. ($12,742)
2018 $23,867 19 Janssen Scientific Affairs, LLC ($11,377)
2017 $28,474 22 Astellas Pharma Inc ($13,282)

All Payment Transactions

61 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
09/22/2023 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $716.00 General
09/22/2023 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $358.00 General
12/01/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $33.75 General
Category: Cardiovascular & Metabolism
11/30/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $101.29 General
Category: Cardiovascular & Metabolism
11/30/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $58.69 General
Category: Cardiovascular & Metabolism
05/14/2020 Janssen Scientific Affairs, LLC Consulting Fee Cash or cash equivalent $2,500.00 General
03/25/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Travel and Lodging Cash or cash equivalent $709.19 General
Category: Cardiovascular & Metabolism
03/20/2020 Janssen Scientific Affairs, LLC XARELTO (Drug) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: Cardiovascular & Metabolism
03/06/2020 SANOFI US SERVICES INC. Consulting Fee Cash or cash equivalent $1,213.50 General
03/03/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Consulting Fee Cash or cash equivalent $4,640.00 General
Category: Cardiovascular & Metabolism
02/25/2020 SANOFI US SERVICES INC. Consulting Fee Cash or cash equivalent $3,640.50 General
02/21/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $37.00 General
Category: Cardiovascular & Metabolism
02/21/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $26.00 General
Category: Cardiovascular & Metabolism
02/21/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $5.25 General
Category: Cardiovascular & Metabolism
02/17/2020 Janssen Scientific Affairs, LLC XARELTO (Drug) Consulting Fee Cash or cash equivalent $600.00 General
Category: Cardiovascular & Metabolism
11/11/2019 Janssen Scientific Affairs, LLC XARELTO (Drug) Consulting Fee Cash or cash equivalent $800.00 General
Category: Cardiovascular & Metabolism
08/27/2019 SANOFI US SERVICES INC. Consulting Fee Cash or cash equivalent $12,741.75 General
08/12/2019 Janssen Scientific Affairs, LLC XARELTO (Drug) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: Cardiovascular & Metabolism
05/10/2019 Janssen Scientific Affairs, LLC XARELTO (Drug) Consulting Fee Cash or cash equivalent $1,600.00 General
Category: Cardiovascular & Metabolism
02/11/2019 Janssen Scientific Affairs, LLC XARELTO (Drug) Consulting Fee Cash or cash equivalent $1,900.00 General
Category: Cardiovascular & Metabolism
12/17/2018 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $3,685.50 General
11/26/2018 Janssen Scientific Affairs, LLC XARELTO (Drug) Consulting Fee Cash or cash equivalent $3,800.00 General
Category: Cardiovascular & Metabolism
09/13/2018 Janssen Scientific Affairs, LLC XARELTO (Drug) Consulting Fee Cash or cash equivalent $6,000.00 General
Category: Cardiovascular & Metabolism
09/13/2018 Janssen Scientific Affairs, LLC XARELTO (Drug) Travel and Lodging In-kind items and services $486.07 General
Category: Cardiovascular & Metabolism
09/13/2018 Janssen Scientific Affairs, LLC XARELTO (Drug) Travel and Lodging Cash or cash equivalent $109.78 General
Category: Cardiovascular & Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 1,102 1,187 $1.1M $40,527
2022 17 997 1,050 $959,807 $34,078
2021 17 985 1,026 $803,851 $34,383
2020 20 1,013 1,097 $521,366 $31,790
Total Patients
4,097
Total Services
4,360
Medicare Billing
$140,778
Procedure Codes
70

All Medicare Procedures & Services

70 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 67 103 $17,976 $8,819 49.1%
93880 Ultrasound of both sides of head and neck blood flow Facility 2023 234 243 $62,650 $7,842 12.5%
93970 Ultrasound study of arm or leg veins with compression and maneuvers Facility 2023 136 142 $39,521 $4,141 10.5%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 18 18 $4,572 $2,667 58.3%
93975 Complete ultrasound of abdomen and pelvis artery and vein blood flow Facility 2023 54 56 $34,117 $2,548 7.5%
93925 Ultrasound of leg arteries or artery grafts Facility 2023 64 66 $30,064 $2,194 7.3%
93971 Ultrasound study of one arm or leg veins with compression and maneuvers Facility 2023 100 113 $26,990 $2,005 7.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 13 14 $3,142 $1,729 55.0%
93922 Ultrasound study of arm and leg arteries Facility 2023 160 162 $466,845 $1,671 0.4%
93926 Ultrasound of one leg arteries or artery grafts Facility 2023 67 75 $21,528 $1,507 7.0%
93923 Complete ultrasound study of arm and leg arteries Facility 2023 77 80 $373,430 $1,433 0.4%
93930 Ultrasound of arm arteries or artery grafts Facility 2023 37 37 $19,738 $1,224 6.2%
93922 Ultrasound study of arm and leg arteries Office 2023 13 13 $19,180 $1,057 5.5%
93978 Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts Facility 2023 28 29 $11,545 $969.76 8.4%
93990 Ultrasound of hemodialysis access Facility 2023 18 20 $14,814 $389.98 2.6%
93931 Ultrasound of one arm arteries or artery grafts Facility 2023 16 16 $3,362 $331.84 9.9%
93880 Ultrasound of both sides of head and neck blood flow Facility 2022 213 217 $49,696 $7,022 14.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 59 77 $9,900 $5,850 59.1%
93970 Ultrasound study of arm or leg veins with compression and maneuvers Facility 2022 94 94 $23,676 $2,849 12.0%
93971 Ultrasound study of one arm or leg veins with compression and maneuvers Facility 2022 122 132 $25,772 $2,535 9.8%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 15 15 $4,560 $2,521 55.3%
93975 Complete ultrasound of abdomen and pelvis artery and vein blood flow Facility 2022 52 52 $26,263 $2,382 9.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 12 14 $5,264 $1,704 32.4%
93922 Ultrasound study of arm and leg arteries Facility 2022 151 153 $437,580 $1,499 0.3%
93925 Ultrasound of leg arteries or artery grafts Facility 2022 46 46 $17,330 $1,487 8.6%

About Dr. Nicholas Leeper, MD

Dr. Nicholas Leeper, MD is a Cardiovascular Disease healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407044639.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Leeper, MD has received a total of $87,022 in payments from pharmaceutical and medical device companies, with $1,074 received in 2023. These payments were reported across 61 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($67,850).

As a Medicare-enrolled provider, Leeper has provided services to 4,097 Medicare beneficiaries, totaling 4,360 services with total Medicare billing of $140,778. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.

Practice Information

  • Specialty Cardiovascular Disease
  • Location Palo Alto, CA
  • Active Since 10/12/2007
  • Last Updated 04/23/2024
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1407044639

Products in Payments

  • XARELTO (Drug) $38,230
  • SOTAGLIFLOZIN (Drug) $4,450
  • INVOKANA (Drug) $3,273
  • CHANTIX (Drug) $72.18

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in Palo Alto